본문으로 건너뛰기
← 뒤로

Intratumoral heterogeneity in microsatellite instability status at single-cell resolution.

1/5 보강
iScience 📖 저널 OA 100% 2023: 4/4 OA 2024: 21/21 OA 2025: 69/69 OA 2026: 112/112 OA 2023~2026 2026 Vol.29(3) p. 114860 OA
Retraction 확인
출처

Anthony H, Seoighe C

📝 환자 설명용 한 줄

Intratumoral heterogeneity complicates the interpretation of single-test biomarkers.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Anthony H, Seoighe C (2026). Intratumoral heterogeneity in microsatellite instability status at single-cell resolution.. iScience, 29(3), 114860. https://doi.org/10.1016/j.isci.2026.114860
MLA Anthony H, et al.. "Intratumoral heterogeneity in microsatellite instability status at single-cell resolution.." iScience, vol. 29, no. 3, 2026, pp. 114860.
PMID 41767255 ↗

Abstract

Intratumoral heterogeneity complicates the interpretation of single-test biomarkers. Microsatellite instability (MSI) is one such biomarker, which is used to guide immune checkpoint inhibitor treatment by classifying samples as having high microsatellite instability (MSI-H) or as microsatellite stable (MSS). However, it is unknown whether MSI itself is a heterogeneous phenomenon. To test this, we curated data from several single-cell RNA sequencing studies with clinical MSI status and developed a computational pipeline that quantifies intratumoral heterogeneity in MSI. Out of 49 individuals, 15 showed evidence of divergence in MSI status between clusters of cancer cells, and most had distinct MSI-H and MSS subclones. These results question the use of MSI as a binary biomarker, and we hypothesize that accounting for heterogeneity could improve its use as a predictive biomarker. Further studies are required to determine the frequency of MSI heterogeneity at the population level and whether it can have clinical implications.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기